elicited C3H/HeJ peritoneal macrophages to produce nitric oxide in response to lipopolysaccharide. These data support the concept that beta interferon provides an essential signal(s) for lipopolysaccharide-triggered nitric oxide production by mouse macrophages. Heat-killed Staphylococcus aureus, a gram-positive bacterium which was unable to initiate nitric oxide production in thioglycolate-elicited C3HeB/FeJ peritoneal macrophages in vitro, promoted nitric oxide formation in the presence of beta interferon, suggesting that beta interferon may be a general cofactor necessary for bacterium-derived stimulus-induced nitric oxide production in these macrophages. However, neither beta interferon nor tumor necrosis factor alpha, alone or in combination, triggered nitric oxide production in thioglycolate-elicited mouse peritoneal macrophages, demonstrating that these macrophage-derived cytokines, while necessary, were not sufficient by themselves for the induction of nitric oxide production in these cells. On the other hand, gamma interferon and tumor necrosis factor alpha acted together to induce nitric oxide production in vitro in the absence of lipopolysaccharide in thioglycolateelicited mouse peritoneal macrophages, indicating that these two types of interferons provided different signals during the activation of these macrophages.
Nitric oxide (NO), synthesized from L-arginine, is a potent effector molecule produced by many mammalian cell types (36) . For example, NO accounts for the biological activity of the endothelium-derived relaxing factor in endothelial cells (41) . In addition, macrophage-derived NO functions as a cytotoxic molecule for invading microorganisms (1, 2, 22, 25, 39) as well as tumor cells (16, 34, 48) . NO released from Kupffer cells and hepatocytes has inhibitory effects on the total protein synthesis of these cells (9, 10) . Recent reports have suggested that NO synthesis in these cells may serve to reduce hepatic damage during acute murine endotoxemia (26) . Large amounts of NO formation may cause significant nitrosation of amines, which have been implicated in carcinogenesis (31, 35) .
Regulatory mechanisms for NO production were recently studied intensively, and two types of NO synthases were characterized (45) . One is constitutive and Ca2' and calmodulin dependent. The other is Ca2' and calmodulin independent and inducible after immunological activation of macrophages, endothelial cells, and some other cell types. Bacterial lipopolysaccharide (LPS) can increase both blood NO concentration in vivo and production of NO by macrophages in vitro (46) . All three species of interferon (IFN), i.e., alpha interferon (IFN-oa), IFN-P, and IFN--y, are able to augment LPS-induced NO production (4, 13, 47) . In addition, IFN-y in combination with interleukin-lot (IL-la) and/or tumor necrosis factor alpha/beta (TNF-a/p) can interact synergistically to initiate NO production (4, 13) . However, among the cytokines tested to date, including IL-13, IL-2, IL-3, IL-4, IL-6, IFNs, macrophage colony-stimulat-* Corresponding author.
ing factor, granulocyte-macrophage colony-stimulating factor, TNF-a/p, and transforming growth factor beta (TGF-3), IFN--y is the only cytokine which has been reported to be capable of inducing NO production by itself under some experimental conditions in certain murine macrophages (13, 17, 47) . On the other hand, cytokines such as TGF-P-1, TGF-,B-2, TGF-,B-3, IL-10, and macrophage deactivating factor have been shown to inhibit the induction of NO production (12, 22) . Recent reports demonstrated that IL-4 blocked inducible NO production (3). The anti-inflammatory reagents dexamethasone and hydrocortisone have also been shown to prevent NO formation (15, 30) . These studies reflect the fact that inducible NO production is tightly regulated and that a delicate functional balance among various microbial stimuli, host-derived cytokines, and hormones in the microenvironment is very important for this regulation. The significance of this regulation has been particularly implicated in a recent report showing that highdose IL-2 therapy, which is known to induce IFN--y, TNF-a, and IL-1 in vivo, causes a striking increase in circulating levels of NO as well as urinary excretion of stable NO metabolites in patients with advanced cancer (28) .
Several lines of evidence indicate that different regulatory pathways may exist for inducible NO production. First, LPS-induced NO formation has been observed with both nude mice and CBA/N mice, indicating that neither functional T cells nor mature B cells are required for this LPS-initiated response in vivo (4) . In addition, different macrophage cell lines respond differentially to IFN--y activation in terms of NO production (47) : only two cell lines tested in that study (PU5-1.8 and RAW 264.7) can synthesize NO in response to IFN--y, while the other two (WEHI-2 and J774A.1) cannot, although all of these four cell lines can produce NO upon LPS activation. Furthermore, macrophage deactivating factor and TGF-P have been shown to partially block NO release in macrophages activated with IFN--y plus TNF-a; however, these inhibitors are significantly less efficient in the downregulation of IFN--y plus LPS-induced NO formation (12) . Finally, the induction of NO formation by IFN--y plus muramyl dipeptide can be suppressed almost completely by an anti-TNF-a neutralizing antibody, while the same antibody can only modestly inhibit NO formation induced by the combination of IFN--y plus LPS (17) .
Macrophages activated with bacterial stimuli, such as LPS, can secrete a variety of cytokines, including TNF-a (40) and IFN-p (7, 27) . Both of these cytokines function as autocrine or paracrine regulators for macrophage activation (14, 34) . In this manuscript, we have further defined the important regulatory role of the macrophage-derived cytokine IFN-p in bacterial stimulus-induced NO production. We (37) . Although the mutant gene (Lps) has been mapped to a locus on chromosome 4 (43) , the precise mechanism(s) for hyporesponsiveness to LPS has not been defined to date. It has been reported that some LPS-dependent responses can be elicited in vitro by R-chemotype LPS in C3HIHeJ mouse cells (19, 20, 52) . We have confirmed these observations, and the results are shown in Table 1 . Relatively high concentra- Table 1 . The addition of exogenous IFN-,B (e.g., 100 U/ml) enhanced Ra-LPS-induced TNF-a formation (about 15-fold) and enabled S-LPS to initiate the production of TNF-a. The most important point to be made from the data shown in Table 1 , however, is the fact that the addition of exogenous IFN-3 was able to correct the LPS hyporesponsiveness of C3H/HeJ macrophages for LPS-dependent NO production with both S-LPS and Ra-LPS, therefore demonstrating the critical role of IFN-P in inducible NO formation in response to LPS in mouse TG-elicited peritoneal macrophages. The effect of exogenous IFN-y on these LPS-induced responses in C3H/HeJ TG-elicited peritoneal macrophages was also examined with similar experimental procedures, and the results of these studies are summarized in Table 2 .
Like IFN-P, IFN--y can restore the capacity of LPS to induce NO production, in addition to enhancing the effects of LPS on the induction of TNF-a production. Therefore, the necessary signal(s) required for LPS-initiated NO formation in murine TG-elicited peritoneal macrophages can be supplied by IFN-y as well. It should be noted, however, that under the experimental conditions described, neither preparation of IFN was capable of eliciting NO production in the absence of LPS (data not shown).
Effects of IFN-13 on S. aureus-induced NO production in C3HeB/FeJ TG-elicited peritoneal macrophages. We previously reported that in C3HeB/FeJ macrophages, heat-killed S. aureus, a gram-positive bacterium, does not induce NO formation under experimental conditions in which the production of other inflammatory mediators, such as TNF-ot, can readily be initiated (51) . We therefore questioned whether IFN-, might also be able to act as a cofactor for S.
aureus-induced NO production in macrophages. In these experiments, C3HeB/FeJ TG-elicited peritoneal macrophages were stimulated with heat-killed S. aureus in the presence of various concentrations of IFN-,B for 24 h. Cultures receiving no IFN-1 served as controls. As shown by the data in Fig. 2 , S. aureus in the absence of IFN-3 was able to stimulate the production of TNF-a. However, the addition of IFN-,B provided a necessary signal(s) for S. aureus-induced NO production in a dose-dependent manner. Therefore, these results suggest that IFN-,B may serve as a general cofactor which is required for inducible NO formation in mouse TG-elicited peritoneal macrophages. In contrast to NO production, S. aureus-induced TNF-a production, as measured in 6-h culture supernatants from the same macrophage cultures, was not significantly affected by the addition of exogenous IFN-,. This phenomenon may suggest either that IFN-p is not absolutely required for S. aureus-induced TNF-a formation or, alternatively, that the dose of S. aureus used in these experiments may have been sufficiently high to already have maximized TNF-a levels and therefore that added exogenous IFN-3 would not have been capable of enhancing TNF-at production to any further extent under such experimental conditions. Effects of cytokines on NO production in the absence of LPS in C3HeB/FeJ TG-elicited macrophages. It has been reported that the presence of an anti-TNF-ax antibody in cultures of LPS-stimulated macrophages can partially inhibit macrophage-dependent NO production induced by IFN--y and LPS (17) . We therefore questioned whether LPS might trigger NO formation indirectly in macrophages via the induction of TNF-a and IFN-1, which would then act in a coordinate fashion to induce NO formation. To address this question, C3HeB/FeJ TG-elicited peritoneal macrophages were treated with various concentrations of recombinant TNF-a and/or IFN-1, alone or in combination, for 18 h. Macrophages activated with E. coli O111:B4 S-LPS in parallel wells served as a positive control for these experiments. As shown by the data in Table 3 , under experimental conditions in which significant amounts of NO production could be readily initiated by 100 ng of E. coli O111:B4 S-LPS per ml, neither TNF-a nor IFN-13, alone or in combination, was capable of inducing any significantly detectable levels of NO formation.
It was shown previously that, in C3H/He LPS-responsive TG-elicited peritoneal macrophages, LPS-induced NO production becomes detectable after 12 h of activation, while substantial amounts of NO metabolites produced by these macrophages are present in culture supernatants after 24 h of LPS stimulation. NO formation increases continuously and reaches plateau levels at about 48 h postactivation (47) . It is possible, in the experiments shown in Table 3 , that the time allowed for the activation of macrophages with these cytokines was insufficient or that the concentrations of these cytokines used were inappropriate for the detection of any stimulatory effects. However, when we carried out similar experiments in which cells were incubated with higher concentrations of IFN-,B (from 500 to 50,000 U/ml) and/or TNF-a (from 1,250 to 10,000 U/ml), alone or in combination, or for longer times of culturing (24 h to that in the earlier published studies. Nevertheless, it is clear from these results that IFN--y synergistically interacts with TNF-ot to induce NO formation, while under similar experimental conditions, IFN-1 does not. These data would therefore support the concept that the signals provided by IFN-,B and IFN--y for inducible NO production in mouse TG-elicited peritoneal macrophages are not identical.
DISCUSSION
In this study, we showed that an anti-IFN-,B neutralizing MAb significantly reduced LPS-initiated NO production in C3HeB/FeJ TG-elicited peritoneal macrophages and that the addition of exogenous recombinant IFN-,B was capable of restoring the ability of LPS-hyposensitive C3H/HeJ TGelicited peritoneal macrophages to respond to LPS by producing NO. These results therefore demonstrate that IFN-p is a critical autocrine regulator for LPS-induced NO formation in mouse TG-elicited peritoneal macrophages. Furthermore, exogenous IFN-p enabled heat-killed S. aureus to stimulate NO production in mouse TG-elicited peritoneal macrophages, suggesting that IFN-,B may be required not only for the LPS-induced response but also for other bacterial stimulus-induced NO production as well. The fact that the neutralizing MAb against IFN-1 was also able to inhibit LPS-induced NO production in macrophage-like cell line RAW 264.7 demonstrated that IFN-,B has autocrine regulatory functions in other macrophages. The requirement for IFN-1 in NO production is consistent with the results of other laboratories showing that LPS-induced activation of bone marrow culture-derived mouse macrophages for tumor cell killing can be abolished by a polyclonal antiserum specific for IFN-a/,3 (34) .
Our studies have suggested that a neutralizing MAb to IFN-,, but not IFN-a, inhibits LPS-induced NO formation. One of the possible reasons for the relative inefficiency of the anti-IFN-a MAb in inhibiting NO production is that LPSstimulated TG-elicited peritoneal macrophages appear to produce predominantly IFN-,, and not IFN-ot (7, 27) . Alternatively, the neutralizing titer of the anti-IFN-a antibody used in our experiments may not be sufficiently high to allow the detection of any inhibitory effects. A recent report suggests that both subspecies of type I IFNs (IFN-ot and IFN-p) share a common component (8) . It has been shown that IFN-ax is able to augment LPS-initiated NO production (13 (5, 18, 50) . These findings would suggest that whole killed bacterial particles and purified individual components from these bacteria may have different immunostimulatory activities. Recent studies from our laboratories with gram-negative bacteria and the bacterial constituents lead to the same conclusion (33a) .
We have demonstrated here that neither IFN-1 nor TNF-a, alone or in combination, can induce detectable NO secretion under experimental conditions in which LPS can initiate a substantial amount of NO production. These results indicate that a costimulatory signal(s) provided exclusively by bacterial stimuli, such as LPS, in addition to those provided by IFN-3 and TNF-ot, is required for macrophage NO production. The fact that IFN--y plus TNF-a, in contrast, can initiate NO production in the absence of LPS clearly indicates that the signals provided by these two types of IFN for NO production are not identical. IFN--y has been shown to induce IFN-3 production in peritoneal macrophages from normal LPS-responsive mice (ips'), as assessed by the accumulation of IFN-, mRNA in hybridization assays and the secretion of IFN-P protein in neutralization assays with MAbs (23, 24) . Moreover, IFN--y alone stimulated IFN-,B production by posttranscriptional mechanisms in peritoneal macrophages from C3H/HeJ LPS-hyporesponsive mice (lps), whereas LPS did not induce IFN-1 production in these lpsd peritoneal macrophages (24, 49) . Therefore, the defect of C3H/HeJ macrophages in response to LPS is likely to be, as least in part, due to the inability of these cells to produce IFN-P upon LPS stimulation. The fact that IFN--y is able to promote the production of IFN-1 may account, at least in part, for the IFN-y complementation of LPS in the induction of NO production by C3HIHeJ peritoneal macrophages. IFN--y may also provide positive signals for LPS-induced TNF-a production, another way in which this cytokine could render LPS more potent in generating NO production in C3H/HeJ peritoneal macrophages.
In animal models of endotoxemia, acute hypotension has been attributed to vigorous, unregulated NO 
